OptiBiotix’s Health Plc – How Your Gut Bacteria May Be Thwarting Your Diet

Forbes published an article which talks about a new study found in the journal Cell Host & Microbe and offers some clues as to why sometimes the body doesn’t seem to respond to changes in eating habits in the way it “should.” It finds that the effects of switching from a typical unhealthy American diet to a calorie-restricted plant-based diet are slowed because of the stubborn microbes that have proliferated during our prior (unhealthy) ways.

We spoke to Stephen OHara, OptiBiotix’s Health Plc CEO, who said: ‘This article reports new scientific understanding on factors influencing sustainable weight loss. The evidence suggests that people with a greater microbial diversity may be able to respond more quickly to dieting and are more able to sustain weight loss than those with less microbial diversity. People who have fast food diets tend to have a restricted microbial diversity and this study would suggest that loosing and sustaining weight loss may be more difficult in these groups. GoFigure® products containing SlimBiome®, OptiBiotix’s patented formulation of ingredients developed by experts to support weight loss, includes a prebiotic designed to enhance microbial diversity which this research suggests is likely to help people loose weight more quickly and sustain this weight loss. This creates the opportunity for easier and more sustainable weight loss than would be achieved with more traditional diets’.

OptiBiotix Health Plc (LON:OPTI) is a life sciences company operating in one of the most progressive areas of biotechnological research – the modulation of the human microbiome. Company products are designed to improve consumer health and wellbeing and support the prevention and management of chronic lifestyle disorders (hypercholesterolemia, obesity and diabetes). These markets have enormous potential driven by macro environmental factors, including an ageing population, rising medical costs, a public health policy shift towards disease prevention and consumer trends towards healthier lifestyles, better nutrition and self help. Opti is at the leading edge of this evolving field and with its validated technology platforms is well positioned to exploit increasing public, political and investor interest in this field.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Optibiotix Health Plc

    More articles like this

    Optibiotix Health Plc

    NutraIngredients Awards shortlist announced

    NutraIngredients is pleased to announce the shortlisted finalists for the 2018 edition of the NutraIngredients Awards … with the winners announced at our exclusive awards evening in Geneva on 16th May. The shortlisted finalistsfor the 10

    Optibiotix Health Plc

    OptiBiotix Health plc Launch of Slimbiome® in Nutri-bites®

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, and high cholesterol, today announced the launch of its award winning SlimBiome® in Nutri-Bites® with its US partner, Cereal Ingredients (“CII”), at the 2018 Natural

    Optibiotix Health Plc

    OptiBiotix Health PLC OptiBiotix Capital Reorganisation

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek a cancellation of its share premium account (the “Capital Reduction”) in

    Optibiotix Health Plc

    Optibiotix Health PLC In a Strong Position

    Optibiotix Health PLC (LON:OPTI) Chief Executive Officer Stephen O’Hara talks to tells Proactive Investors about focussing on the commercialisation of their technology across the company’s platforms.

    Optibiotix Health Plc

    Functional weight loss ingredient, SlimBiome brought to US

    OptiBiotix Health PLC (LON:OPTI), a specialist in the development of functional ingredients to modulate the human microbiome, has entered into a manufacturing and supply agreement with Cereal Ingredients. The agreement grants Cereal Ingredients a licence to

    Optibiotix Health Plc

    SlimBiome® – Supporting hunger-free weight management

    Slimbiome® is OptiBiotix’s patented combination of natural ingredients, identified and developed by leading experts in nutrition and metabolism, which supports scientifically substantiated weight loss claims. In independent tests the component ingredients have shown reductions in calorie intake

    Optibiotix Health Plc

    OptiBiotix Health PLC Proposed Directorate Changes

    OptiBiotix Health PLC (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, today announced that subject to the completion of normal regulatory due diligence Neil Davidson CBE will be appointed as Non- Executive Chairman on 1 January 2018. Adam Reynolds, the current Non-Executive Chairman will

    Optibiotix Health Plc

    Optibiotix Health PLC on Kelloggs’ Sugar Levels Cut

    Following the announcement today from Kelloggs to cut the amount of sugar in its three top selling children’s cereals, we caught up with Stephen O’Hara, CEO of OptiBiotix Health PLC (LON:OPTI) for his thoughts:   “We are really